NeuBase Therapeutics, Inc. (NBSE) SEC filings
NBSE SEC filings moved a median of +5.08% by the close. NBSE SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the NBSE overview →
19 measured NBSE SEC filing events.
Where these NBSE SEC filings landedvs 11 measured NBSE SEC filing reactions
| Middle 50% of NBSE SEC filing reactions | +1.25% to +7.40% |
|---|---|
| Median reaction (to close) | +5.08% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 NBSE SEC filing events with a measured close landed between +1.25% and +7.40%; 82% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form EFFECT NeuBase Therapeutics, | SEC filing · Form EFFECT | — | — | |
| Form 15-12G NeuBase Therapeutics, | SEC filing · Form 15-12G | — | — | |
| Form 8-K NeuBase Therapeutics, For: Jun 26 | SEC filing · Form 8-K | — | — | |
| Form POS AM NeuBase Therapeutics, | SEC filing · Form POS | — | — | |
| Form S-8 POS NeuBase Therapeutics, | SEC filing · Form S-8 | — | — | |
| Form 8-K NeuBase Therapeutics, For: May 22 | SEC filing · Form 8-K | — | — | |
| Form DEFA14A NeuBase Therapeutics, | SEC filing · Form DEFA14A | — | — | |
| Form 8-K NeuBase Therapeutics, For: May 13 | SEC filing · Form 8-K | — | — | |
| Form DEFA14A NeuBase Therapeutics, | SEC filing · Form DEFA14A | -3.08% | +8.89% | |
| Form 8-K NeuBase Therapeutics, For: May 02 | SEC filing · Form 8-K | -3.08% | +8.89% | |
| Form DEF 14A NeuBase Therapeutics, For: May 13 | SEC filing · Form DEF | +0.00% | +2.61% | |
| Form 8-K NeuBase Therapeutics, For: Apr 04 | SEC filing · Form 8-K | -6.21% | -2.76% | |
| Form PRE 14A NeuBase Therapeutics, For: May 13 | SEC filing · Form PRE | +5.50% | +7.50% | |
| Form 8-K NeuBase Therapeutics, For: Mar 05 | SEC filing · Form 8-K | -2.75% | +0.56% | |
| Form 8-K NeuBase Therapeutics, For: Feb 22 | SEC filing · Form 8-K | -2.33% | +7.30% | |
| Form 8-K NeuBase Therapeutics, For: Jan 26 | SEC filing · Form 8-K | +8.33% | +5.08% | |
| Form 8-K NeuBase Therapeutics, For: Jan 12 | SEC filing · Form 8-K | +0.00% | +1.93% | |
| Form 8-K NeuBase Therapeutics, For: Dec 27 | SEC filing · Form 8-K | — | -4.45% | |
| Form 8-K NeuBase Therapeutics, For: Dec 20 | SEC filing · Form 8-K | -2.71% | +6.87% |
Keep exploring
More NBSE: earnings → · analyst actions → · NBSE overview →